Literature DB >> 66176

Pharmacology and potential use of cyproterone acetate.

F Neumann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 66176     DOI： 10.1055/s-0028-1093574

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  16 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  The effect of cyproterone acetate on adrenal cortical function in children with precocious puberty.

Authors:  F Heinze; W M Teller; H L Fehm; A Joos
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

3.  Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.

Authors:  G Valenti; P P Vescovi; G Gerra; G Rastelli; U Butturini
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

4.  Effects of cyproterone acetate on sexual arousal patterns of pedophiles.

Authors:  J M Bradford; A Pawlak
Journal:  Arch Sex Behav       Date:  1993-12

5.  Characterization of human androgen receptor overexpressed in the baculovirus system.

Authors:  C Chang; C Wang; H F DeLuca; T K Ross; C C Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 6.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

7.  Effect of antiandrogen flutamide on measures of hepatic regeneration in rats.

Authors:  G W Svanas; P K Eagon; M Elm; L Makowka; L Podesta; P Chapchap; D Kahn; T E Starzl; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

8.  Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.

Authors:  Y Sahin; F Bayram; F Keleştimur; I Müderris
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

9.  Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.

Authors:  W Urdl
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

10.  Cyproterone acetate-promoted prevention of renal cortical necrosis following testosterone and vasopressin administration.

Authors:  Z Mónus; F A László
Journal:  Br J Exp Pathol       Date:  1979-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.